Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
65.56
-4.47 (-6.38%)
At close: Mar 23, 2026
SHA:688336 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 459.49 | 933.26 | 1,091 | 1,614 |
Short-Term Investments | - | 863.59 | 344.19 | - | - |
Trading Asset Securities | - | 910.54 | 603.87 | 1,486 | 752.05 |
Cash & Short-Term Investments | 1,724 | 2,234 | 1,881 | 2,577 | 2,366 |
Cash Growth | -22.83% | 18.73% | -27.00% | 8.93% | -14.31% |
Accounts Receivable | - | 147.14 | 133.24 | 149.35 | 256.97 |
Other Receivables | - | 0.03 | 0.2 | 0.29 | 0.53 |
Receivables | - | 147.17 | 133.44 | 149.65 | 257.5 |
Inventory | - | 229.6 | 194.96 | 227 | 210.14 |
Other Current Assets | - | 49.64 | 40.09 | 32.54 | 38.09 |
Total Current Assets | - | 2,660 | 2,250 | 2,986 | 2,872 |
Property, Plant & Equipment | - | 1,539 | 1,562 | 1,426 | 1,371 |
Long-Term Investments | - | 1,140 | 1,020 | 109.4 | 122.37 |
Goodwill | - | 0.64 | 0.64 | 0.64 | 0.64 |
Other Intangible Assets | - | 223.96 | 240.16 | 195.73 | 196.55 |
Long-Term Deferred Tax Assets | - | 129.62 | 145.74 | 173.43 | 155.31 |
Long-Term Deferred Charges | - | 228.54 | 44.44 | 114.02 | 97.67 |
Other Long-Term Assets | - | 43.68 | 42.16 | 92.76 | 73.59 |
Total Assets | - | 5,965 | 5,305 | 5,098 | 4,889 |
Accounts Payable | - | 34.96 | 21.93 | 15.91 | 16.27 |
Accrued Expenses | - | 174.93 | 181.2 | 56.18 | 127.71 |
Short-Term Debt | - | 50.02 | 50.03 | 150.1 | - |
Current Income Taxes Payable | - | 1.3 | 1.3 | 1.2 | 0.21 |
Current Unearned Revenue | - | 20.2 | 16.77 | 19.55 | 3.25 |
Other Current Liabilities | - | 35.49 | 36.91 | 132.15 | 68.01 |
Total Current Liabilities | - | 316.91 | 308.14 | 375.09 | 215.45 |
Long-Term Unearned Revenue | - | 111.24 | 118.33 | 123.79 | 134.28 |
Total Liabilities | - | 428.15 | 426.47 | 498.88 | 349.73 |
Common Stock | - | 616.79 | 616.79 | 616.79 | 616.21 |
Additional Paid-In Capital | - | 2,310 | 2,303 | 2,309 | 2,301 |
Retained Earnings | - | 2,639 | 1,985 | 1,691 | 1,641 |
Comprehensive Income & Other | - | 2.44 | -8.71 | -10.67 | -17.33 |
Total Common Equity | 5,899 | 5,568 | 4,896 | 4,606 | 4,542 |
Minority Interest | - | -30.76 | -17.58 | -6.32 | -2.46 |
Shareholders' Equity | 5,859 | 5,537 | 4,879 | 4,600 | 4,539 |
Total Liabilities & Equity | - | 5,965 | 5,305 | 5,098 | 4,889 |
Total Debt | - | 50.02 | 50.03 | 150.1 | - |
Net Cash (Debt) | 1,724 | 2,184 | 1,831 | 2,427 | 2,366 |
Net Cash Growth | -21.06% | 19.24% | -24.55% | 2.59% | -14.31% |
Net Cash Per Share | 2.79 | 3.53 | 2.98 | 3.94 | 3.93 |
Filing Date Shares Outstanding | 628.61 | 616.79 | 616.79 | 616.79 | 616.21 |
Total Common Shares Outstanding | 616.79 | 616.79 | 616.79 | 616.79 | 616.21 |
Working Capital | - | 2,343 | 1,942 | 2,611 | 2,656 |
Book Value Per Share | 9.56 | 9.03 | 7.94 | 7.47 | 7.37 |
Tangible Book Value | 5,685 | 5,343 | 4,655 | 4,409 | 4,344 |
Tangible Book Value Per Share | 9.22 | 8.66 | 7.55 | 7.15 | 7.05 |
Buildings | - | 626.77 | 626.77 | 531.48 | 531.48 |
Machinery | - | 1,220 | 1,196 | 1,043 | 1,035 |
Construction In Progress | - | 749.65 | 687.81 | 717.11 | 572.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.